Many cardiologists are earning more in 2026 than they did in 2025. However, there is a fear that compensation and wRVUs can only climb so far in this current healthcare environment before things start to stall. 

“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.

Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 

Scientia Vascular, a medtech company focused on advanced stroke therapies, is now officially part of Medtronic. 

Funds with help bring its cellular therapeutics to market in the next year.

These programs may provide benefits in some cases. In others, however, there is a concern that they could actually lead to higher costs over time.